Milae Bioresources Co Ltd
KOSDAQ:218150
Balance Sheet
Balance Sheet Decomposition
Milae Bioresources Co Ltd
Milae Bioresources Co Ltd
Balance Sheet
Milae Bioresources Co Ltd
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1 434
|
1 415
|
15 196
|
2 081
|
4 465
|
2 811
|
36 297
|
15 103
|
1 992
|
4 835
|
|
| Cash |
0
|
0
|
0
|
2 083
|
4 465
|
2 812
|
18 149
|
7 552
|
3
|
4
|
|
| Cash Equivalents |
1 434
|
1 415
|
15 196
|
2
|
0
|
1
|
18 148
|
7 552
|
1 990
|
4 831
|
|
| Short-Term Investments |
7 000
|
7 095
|
715
|
8 761
|
9 206
|
9 422
|
8 848
|
19 126
|
22 548
|
8 101
|
|
| Total Receivables |
63
|
69
|
5 430
|
7 406
|
9 613
|
8 766
|
8 569
|
9 295
|
7 932
|
12 136
|
|
| Accounts Receivables |
62
|
54
|
5 292
|
7 375
|
9 596
|
8 739
|
8 486
|
9 210
|
7 821
|
12 114
|
|
| Other Receivables |
1
|
15
|
138
|
31
|
17
|
27
|
84
|
85
|
110
|
23
|
|
| Inventory |
0
|
0
|
2 968
|
3 381
|
2 687
|
3 358
|
5 103
|
5 116
|
4 335
|
6 442
|
|
| Other Current Assets |
0
|
0
|
540
|
745
|
669
|
955
|
854
|
882
|
1 129
|
1 604
|
|
| Total Current Assets |
8 496
|
8 580
|
24 849
|
22 374
|
26 639
|
25 313
|
41 524
|
41 972
|
37 935
|
33 117
|
|
| PP&E Net |
0
|
0
|
5 425
|
10 753
|
11 086
|
11 263
|
11 436
|
11 387
|
11 191
|
21 098
|
|
| PP&E Gross |
0
|
0
|
0
|
10 753
|
11 086
|
11 263
|
11 436
|
11 387
|
11 191
|
21 098
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
2 061
|
2 721
|
3 622
|
3 897
|
4 617
|
5 447
|
14 866
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
481
|
408
|
240
|
179
|
3 412
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
1 156
|
1 156
|
1 586
|
1 229
|
5 777
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
200
|
499
|
2
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
686
|
958
|
793
|
1 051
|
368
|
908
|
1 057
|
504
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
1 156
|
1 156
|
1 586
|
1 229
|
5 777
|
|
| Total Assets |
8 496
N/A
|
8 580
+1%
|
30 960
+261%
|
34 085
+10%
|
38 519
+13%
|
39 064
+1%
|
55 390
+42%
|
56 095
+1%
|
51 591
-8%
|
63 909
+24%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
1 560
|
1 185
|
3 586
|
2 437
|
3 290
|
2 162
|
1 980
|
3 208
|
|
| Accrued Liabilities |
0
|
0
|
24
|
414
|
431
|
358
|
360
|
505
|
449
|
706
|
|
| Short-Term Debt |
0
|
0
|
2 103
|
3 667
|
3 400
|
4 424
|
2 322
|
2 591
|
2 686
|
9 931
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
500
|
0
|
162
|
137
|
193
|
8 404
|
745
|
1 093
|
|
| Other Current Liabilities |
0
|
0
|
623
|
341
|
1 006
|
869
|
1 268
|
1 278
|
1 267
|
1 972
|
|
| Total Current Liabilities |
0
|
0
|
4 810
|
5 607
|
8 586
|
8 224
|
7 432
|
14 941
|
7 126
|
16 910
|
|
| Long-Term Debt |
1 479
|
1 506
|
1 455
|
0
|
216
|
152
|
14 856
|
311
|
288
|
480
|
|
| Deferred Income Tax |
29
|
26
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
302
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
238
|
174
|
89
|
7
|
2 086
|
|
| Other Liabilities |
0
|
0
|
32
|
56
|
56
|
1
|
43
|
8
|
16
|
546
|
|
| Total Liabilities |
1 508
N/A
|
1 533
+2%
|
6 297
+311%
|
5 663
-10%
|
8 858
+56%
|
8 615
-3%
|
22 505
+161%
|
15 350
-32%
|
7 438
-52%
|
20 324
+173%
|
|
| Equity | |||||||||||
| Common Stock |
353
|
353
|
1 710
|
1 867
|
1 867
|
1 867
|
1 867
|
1 990
|
2 042
|
2 042
|
|
| Retained Earnings |
17
|
77
|
15 158
|
16 934
|
17 964
|
18 914
|
20 057
|
21 019
|
21 447
|
20 989
|
|
| Additional Paid In Capital |
6 618
|
6 618
|
8 748
|
9 858
|
10 062
|
10 271
|
11 663
|
18 423
|
21 329
|
21 329
|
|
| Treasury Stock |
0
|
0
|
0
|
775
|
775
|
1 041
|
995
|
979
|
979
|
979
|
|
| Other Equity |
0
|
0
|
952
|
538
|
542
|
438
|
293
|
293
|
315
|
205
|
|
| Total Equity |
6 988
N/A
|
7 047
+1%
|
24 664
+250%
|
28 423
+15%
|
29 661
+4%
|
30 449
+3%
|
32 885
+8%
|
40 745
+24%
|
44 153
+8%
|
43 585
-1%
|
|
| Total Liabilities & Equity |
8 496
N/A
|
8 580
+1%
|
30 960
+261%
|
34 085
+10%
|
38 519
+13%
|
39 064
+1%
|
55 390
+42%
|
56 095
+1%
|
51 591
-8%
|
63 909
+24%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
4
|
4
|
16
|
18
|
18
|
18
|
18
|
19
|
19
|
19
|
|